Cubist Pharmaceuticals, Inc.
Records under this name other than the patents Cubist Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Back to Cubist Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,507,647 | Novel Antibacterial Agents for the Treatment of Gram Positive Infections Formerly held In force · High confidence | In force | High confidence | |
| US 8,906,866 | Antibiotic Compositions for the Treatment of Gram Negative Infections Formerly held In force · High confidence | In force | High confidence | |
| US 8,415,307 | Antibiotic Compositions for the Treatment of Gram Negative Infections Formerly held In force · High confidence | In force | High confidence | |
| US 8,968,781 | Therapeutic Compositions Formerly held In force · High confidence | In force | High confidence | |
| US 9,193,729 | Inhibiting Transient Receptor Potential Ion Channel TRPA1 Formerly held In force · High confidence | In force | High confidence | |
| US 9,724,353 | Methods for Treating Intrapulmonary Infections Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,028,963 | Methods for Treating Intrapulmonary Infections Formerly held In force · Low confidence | In force | Low confidence | |
| US 8,476,425 | Tazobactam Arginine Compositions Formerly held In force · High confidence | In force | High confidence | |
| US 8,916,709 | 1,2,4-Oxadiazole and 1,2,4-Thiadiazole Beta-Lactamase Inhibitors Formerly held In force · High confidence | In force | High confidence | |
| US 8,927,724 | Isoxazole Beta-Lactamase Inhibitors Formerly held In force · High confidence | In force | High confidence |